Do bone morphogenic protein-4 antagonists have any role in the treatment of human hypertension?

Yeter, Ekrem; Kurt, Mustafa; Özçakar, Bülent; E. Denktaş, Ali

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all

pdf

Do bone morphogenic protein-4 antagonists have any role in the treatment of human hypertension? [Anatol J Cardiol]

Anatol J Cardiol. 2009; 9(4): 356-357

Do bone morphogenic protein-4 antagonists have any role in the treatment of human hypertension?

Ekrem Yeter¹, Mustafa Kurt², Bülent Özçakar³, Ali E. Denktaş⁴
¹Clinic of Cardiology, Ministry of Health Dışkapı Yıldırım Beyazıt Research and Educational Hospital, Ankara-Turkey
²Clinic of Cardiology, Erzurum Education and Research Hospital, Erzurum-Turkey
³Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, Texas
⁴Division of Cardiovascular Medicine, University of Texas Health Science Center and Memorial Hermann Heart and Vascular Institute, Houston, Texas, USA

Ekrem Yeter, Mustafa Kurt, Bülent Özçakar, Ali E. Denktaş. Do bone morphogenic protein-4 antagonists have any role in the treatment of human hypertension?. Anatol J Cardiol. 2009; 9(4): 356-357
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Similar articles PubMed Google Scholar

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all